Pharmacologic Pain Management for the Clinical Professional

 

In this webinar with pain expert Pamela Davies MS, APRN, ACHPN, RN-BC, you will learn in depth information about pain management. Among the topics covered are analgesics, opioids, non-opioid pain treatment, as well as the topic of opioid overdose and its treatment. You will discover the unique characteristics of pain management in older adults and for those with chronic pain. By comparing two different individuals, you will explore how the meaning of pain affects the perception of pain. You will practice dosing for those who are opiate tolerant versus opiate naïve in several examples. This webinar will enhance your knowledge of pain medications so that you can apply it to many care settings.

$20.00

Hours: 2.00
REL-PAL-0-PPMCP

Certificates

Certificates provided by accrediting body (10 Match)

Accreditation Council for Continuing Medical Education

2.0 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Florida Physician Assistants

2.0 HOURS


California Board of Registered Nursing

2.0 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 2.00 contact hours for participating in this course.

District of Columbia Board of Nursing

2.0 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 2.00 contact hours for participating in this course.

Florida Board of Nursing CE

2.0 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 2.00 contact hours for participating in this course.

American Nurses Credentialing Center

2.0 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 2.00 contact hours for participating in this course.

Georgia Board of Nursing

2.0 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 2.00 contact hours for participating in this course.

South Carolina Board of Nursing

2.0 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

Florida Board of Medicine

2.0 HOURS


Florida Board of Medicine CE Provider #: 50-290

West Virginia Board of Registered Nursing

2.0 HOURS


Course Details

Course Code: REL-PAL-0-PPMCP
Hours: 2
Type: Online Course
Content Expiration Date: 6/30/2020
Learning Objectives:
Describe 2 physiological changes that impact the analgesic drug and dose selection for an older adult experiencing pain.

State a unique feature of methadone that impacts its safety when used for pain management.

Describe the management of an acute pain crisis in advanced cancer.

State 2 factors that increase the likelihood of an accidental overdose of prescribed opioids.

State 2 opioid side effects that improve over time, and one that does not improve over time.

State 2 classes of drugs that are useful for managing neuropathic pain.

Outline:
Section 1: Introduction A. Learning Objectives B. Acronyms C. Overview Section 2: Analgesic Therapy Considerations A. Brief Review of Pharmacology B. Analgesic Classes and Their Uses C. Analgesics in the Older Adult D. Types of Pain by Etiology E. Types of Pain by Source and Duration F. Establish the Goals of Therapy for Pain Management G. Pain Not Responding as Expected? Consider… H. Beware Treating Pain Intensity Alone! I. Always Assess the Meaning of Pain! J. Compare These Post-Operative Patients in PACU K. Which Woman Experienced More Pain? Why? L. Always Consider the MEANING of the Pain? M. Knowledge Check N. Knowledge Check Answer Section 3: Opioids (Narcotics) A. Opioids B. Considerations in Selection of Opioids C. Opioids: Benefits versus Harms D. Opioids: Route of Administration E. A Wise Word Regarding Route of Administration F. Considerations in Selection of Opioids: Cost, Availability, and Insurance G. Considerations in Selection of Opioids: Renal or Hepatic Insufficiency H. Considerations When Initiating an Opioid: Onset of Action, Peak, Half-Life, and Duration of Analgesia I. Considerations When Initiating an Opioid: Opioid Selection J. Considerations When Initiating an Opioid: Dosing Pattern K. Opioid Initiation Example: Opioid-Naïve Patient with Acute Moderate-Severe Cancer Pain L. NCCN Guidelines for Adult Cancer Pain M. Opioid Initiation Example: Opioid-Naïve Patient with Acute Moderate-Severe Cancer Pain N. Opioid Initiation Example: Opioid-Tolerant Patient with Acute Moderate-Severe Cancer Pain O. Considerations When Initiating an Opioid: Opioid Tolerance P. Opioid Conversion Practice: 1a Q. Opioid Conversion Practice: 1b Adding an Extended-Release Opioid R. Opioid Conversion Practice: 2a IV Morphine to Oral Oxycodone S. Opioid Conversion Practice: 2b IV Morphine to Oral Oxycodone T. Opioid Conversion Practice: 2c IV Morphine to Oral Oxycodone U. Opioid Conversion Practice: 2d IV Morphine to Oral Oxycodone V. Opioid Conversion Practice: 2e IV Morphine to Oral Oxycodone W. Opioid Conversion Practice: 2f IV Morphine to Oral Oxycodone X. Knowledge Check Y. Knowledge Check Answer Section 4: Other Opioids A. Other Opioids: Methadone (Dolophine®) B. Methadone Initiation C. Other Opioids: Buprenorphine D. Other Opioids: Tramadol & Tapentadol E. Opioids Not Recommended F. Opioid Adverse Effects -1 G. Opioid Adverse Drug Effects -2 H. Opioid Adverse Drug Effects -3 I. Opioid Adverse Drug Effects – 4 J. Document Follow-Up with the 5-A’s K. CDC Opioid Guidelines: Special Populations L. Naloxone (Narcan™) Nasal Spray for Opioid Overdose M. Knowledge Check N. Knowledge Check Answer Section 5: Adjuvant Agents/Neuromodulators A. Adjuvant Analgesics / Neuromodulators B. Adjuvant Analgesics: Anticonvulsants & Mechanism C. Adjuvant Analgesics: Anticonvulsants D. Adjuvant Analgesics: Antidepressants E. Adjuvant Analgesics: Antidepressants - Mechanism F. Adjuvant Analgesic Antidepressants G. Adjuvant Analgesic Antidepressants Tricyclic Antidepressants H. Antidepressants: Keys to Success I. Knowledge Check J. Knowledge Check Answer Section 6: Non-Opioid Analgesics/Co-Analgesics A. Non-Opioid Analgesics: Co-Analgesics B. Non-Opioid Analgesics: Topical Agents C. Topical Agents: Capsaicin (Zostrix®) D. Topical Agents: Capsaicin Over-The-Counter E. Topical Agents: Capsaicin 8% (High Concentration) Patch: Qutenza® F. Topical Agents: Lidocaine 5% Patch G. Topical Agents: Diclofenac Topical Gel & Patch H. Non-Opioid Analgesics: Acetaminophen I. Non-Opioid Analgesics: Non-steroidal Anti-inflammatory Drugs (NSAIDs) J. Non-Opioid Analgesics: K. COX-2 Inhibitors – Celecoxib (Celebrex®) L. Non-Opioid Analgesics: “Skeletal Muscle Relaxants” M. Knowledge Check N. Knowledge Check Answer Section 6: Conclusion A. Case Study B. References C. Resources

Instructor: Pamela Stitzlein Davies, MS, ARNP, A/GNP-C, ACHPN, RN-BC
Pamela Stitzlein Davies is a highly experienced clinical and academic Nurse Practitioner in the fields of Pain Management, Hospice & Palliative Care, Internal Medicine, and Geriatrics. She was a member of the American Pain Society/American Academy of Pain Medicine guidelines committee for Chronic Opioid Therapy in Chronic Noncancer Pain; and the 2015 and 2010 Washington State Interagency Guideline on Prescribing Opioids for Pain. Ms. Davies is a popular national and regional speaker on topics in pain management and palliative care. She has authored multiple publications, including an award-winning text on cancer pain management for nurses. Areas of expertise include: best practices related to prescribing opioids and other Controlled Substances in the outpatient setting, opioid misuse in the primary care, palliative care or hospice setting, and chronic pain management in the cancer survivor. Disclosure: Pamela Stitzlein Davies, MS, ARNP, A/GNP-C, ACHPN, RN-BC has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry and intermediate level Physicians; entry, intermediate, and advanced level Nurses; in the following settings: Hospice, Palliative Care.
F Tags:
F684, F697
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.